|
ZNF561 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22299947946658E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01320000062333E-08 |
| Normal-vs-Stage2 |
9.5649000000031E-05 |
| Normal-vs-Stage3 |
3.96169996808027E-09 |
| Normal-vs-Stage4 |
2.04150000238101E-08 |
| Stage1-vs-Stage2 |
9.785800E-01 |
| Stage1-vs-Stage3 |
1.009440E-01 |
| Stage1-vs-Stage4 |
3.712100E-02 |
| Stage2-vs-Stage3 |
2.457600E-01 |
| Stage2-vs-Stage4 |
8.231700E-02 |
| Stage3-vs-Stage4 |
4.255400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27389987447657E-10 |
| Normal-vs-AfricanAmerican |
9.355600E-04 |
| Normal-vs-Asian |
6.11320000000193E-05 |
| Caucasian-vs-AfricanAmerican |
9.443000E-01 |
| Caucasian-vs-Asian |
3.905000E-01 |
| AfricanAmerican-vs-Asian |
6.261600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65319999970259E-07 |
| Normal-vs-Female |
1.7142998132158E-10 |
| Male-vs-Female |
4.874600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.01269999947174E-07 |
| Normal-vs-Age(41-60Yrs) |
3.75639996885724E-09 |
| Normal-vs-Age(61-80Yrs) |
7.44720000112054E-08 |
| Normal-vs-Age(81-100Yrs) |
1.829710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.036400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.677760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.156400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.175400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.677200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.786600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.594490E-02 |
| Classical-VS-Follicular |
8.445200E-01 |
| Classical-VS-Other |
8.742200E-01 |
| Classical-VS-Normal |
1.59550000000674E-06 |
| Tall-VS-Follicular |
3.965600E-02 |
| Tall-VS-Other |
3.605000E-01 |
| Tall-VS-Normal |
3.80529999954859E-07 |
| Follicular-VS-Other |
8.512600E-01 |
| Follicular-VS-Normal |
2.1635999999936E-05 |
| Other-VS-Normal |
4.822200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.30340000301399E-08 |
| Normal-vs-N1 |
2.41159999747609E-08 |
| N0-vs-N1 |
3.059600E-02 |
|
|
